Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial

Schenker H, Heß A, Konerth L, Sergeeva M, Prade J, Kleyer A, Reiser M, Hueber A, Englbrecht M, Feist E, Voll R, Bannert B, Baerwald C, Rösch J, Dörfler A, Da Silva JAP, Damjanov N, Schett G, Rech J (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Arthritis and Rheumatology Wiley

Book Volume: 69

Authors with CRIS profile

Hannah Schenker Department of Medicine 3 – Rheumatology and Immunology Andreas Heß Lehrstuhl für Pharmakologie und Toxikologie Laura Konerth Lehrstuhl für Pharmakologie und Toxikologie Marina Sergeeva Lehrstuhl für Pharmakologie und Toxikologie Jutta Prade Lehrstuhl für Pharmakologie und Toxikologie Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology Axel Hueber Department of Medicine 3 – Rheumatology and Immunology Matthias Englbrecht Lehrstuhl für Innere Medizin III Julie Rösch Department of Neuroradiology Arnd Dörfler Department of Neuroradiology Georg Schett Lehrstuhl für Innere Medizin III Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Universität Leipzig

Germany (DE) Centro Hospitalar e Universitário de Coimbra (CHUC)

Portugal (PT) Universitätsklinikum Freiburg

Germany (DE) University of Belgrade / Универзитет у Београду

Serbia (RS) Charité - Universitätsmedizin Berlin

Germany (DE)

How to cite

APA:

Schenker, H., Heß, A., Konerth, L., Sergeeva, M., Prade, J., Kleyer, A.,... Rech, J. (2017). Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial.

MLA:

Schenker, Hannah, et al. "Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial." 2017.

BibTeX: Download